chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial misuse report received on 02 December 2013 from office person Med Asst. A 19-months-old child patients whose gender, medical history and concomitant medications were not reported, received a dose of ADACEL (lot number, route and site of vaccination was not reported) on an unspecified date. It was reported that a patient received ADACEL instead of DTaP for the 4th dose in the DTaP series. Patient did not have any adverse event. List of documents held by sender: none.
Initial report received from a health care provider on 09 October 2007. A 43-year-old male patient had received an intramuscular right deltoid injection of Adacel, lot number C2824AA and two days later complained of lymphadenopathy under his right axilla and right shoulder pain radiating to the right axilla. The patient had diagnosed them self with brachial neuritis based on an Internet search and refused to be evaluated by a physician. The patient last received a dose of Tetanus and Diphtheria vaccine in 2000. No further information was provided and the patient's recovery status was unknown at the time of the report.
Client called office and reported a rash at injection side that was just noticed on 01/22/2021.  Vaccine was given on 01/14/2021.  Client reports that the rash is itchy and red.  Denies blisters or s/s of infection.  I advised her to notify her PCP and seek treatment if indicated.  She also reported eating an egg on 01/21/2021- She states that she doesn't eat eggs often and has not had any problems with them in the past.
nausea, anorexia, elevated liver function test; neg Hep A, B, C panel; nl LFT w/in same day but also tx ATB; Ceftin; x 4 days UTI;
Information has been received from a physician concerning his 9 year old son who at the end of 2008 was vaccinated with first dose of VAQTA (Lot # not provided). In June 2009 and on 17-AUG-2010 the patient received the second and third dose of VAQTA (Lot # not provided). The patient has no relevant medical history, concomitant medications or relevant past drug history. On 17-AUG-2009 the patient received the third dose into his left arm. On 18-AUG-2010, the patient had one episode of bloody diarrhea. It was unknown if there was any relevant laboratory data. As of 18-AUG-2010, it was unknown if the patient will continue to receive VAQTA and he did not experience bloody diarrhea at the time of this report. Additional information has been requested.
Vomiting and headache on the third day after vaccine. Symptoms disappear by itself after taking a nap.
Anaphylactic reaction; This is a spontaneous report from a non-contactable consumer. A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on Feb2021 (Batch/Lot number was not reported) at 71-year-old as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Caller stated she received a call from a community member who received her first dose of the Pfizer COVID-19 vaccine in Feb2021 and had an anaphylactic reaction to the vaccine, she reported this already to the CDC and to her HCP who has reported it as well. Caller was looking for information to give to the member about the possibility of being vaccinated with the Jansen COVID_19 vaccine. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I started feeling a numbness and tingling in my fingers. I called to make an appointment with my doctor to discuss my symptoms. She has sent me for to have bloodwork done to start to rule out diabetes. She said we will start here to see what we learn and go forward. She said it could be something as simple as an allergic reaction to a lotion I am using to possible diabetes.
sick with second dose; still don't feel well; This case was reported by a consumer via (Shingrix) interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2021, the patient received the 2nd dose of Shingrix. In September 2021, less than a month after receiving Shingrix, the patient experienced sickness and feeling unwell. On an unknown date, the outcome of the sickness and feeling unwell were not recovered/not resolved.   The reporter considered the sickness to be related to Shingrix. It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional details were reported as follows. This case was reported by the patient for herself/himself. The age at vaccination was not reported. The patient got the Shingrix vaccine on Friday which made her/him sick. The patient stated that she/he still did not feel well and asked how long did it last. The follow-up would not possible as contact information was not available.
Arthralgia, Fever, CoughWheeze, NauseaVomiting, AXILLARY LYMPHADENOPATHY Narrative:  "I woke in the morning (1/27/2021) with body aches and my arm was very painful I have axillary lymphadenopathy. As the day wore on I developed a fever to 101 and as my temp went up I developed a burning cough like my exercise asthma very mild but annoying. Every joint that I have arthritis in was screaming and I had overwhelming fatigue and nausea. Woke up today completely better with the exception of the axillary lymphadenopathy".
flush all over with a fine rash in it; flush all over with a fine rash in it; headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (age: 70; unit: unknown, as reported) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took morphine [morphine sulfate] and experienced same flushing/rash, took histamine and experienced flushing. It was reported that, patient received 1st dose on friday, approximately one hour after injection- body became flush all over with a fine rash in it. Patient says it took 4 hrs for the flushing to go away, and the rash went away by Saturday. Patient also experienced, headache. Patient says IV morphine causes: same flushing/rash (40 years ago). With histamine injections, had flushing. Patient asks, can the same thing happen with the 2nd dose or could it be worse, should she get the 2nd dose. Patient asks there wasn't an expiration date on my card, should she ask them for an expiration date after her 2nd dose. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
To Whom It May Concern, I am 62 years of age female. I am reaching out because in the summer of 2022 I started to have difficulty reading, writing and talking along with having anxiety and depression. I then went to my doctor and she gave me depression and anxiety medication. I also had a neural psych evaluation and I was diagnosed with MCI. Mild Cognitive Impairment which I feel is a side effect from the Covid Vaccine and Booster. Due to all of these diagnosis I then had to retire from my 28 year job earlier then anticipated due to the MCI. I have done some research with my family and we feel that I am being effected with MCI due to the vaccine and booster. I am healthy and I am within my weight class. I never had any prior health issues and any help would be greatly appreciated because I am a grandmother of 6 grand kids and its my goal in life to be here to see them grow. Below is my contact information. I hope to hear from someone. PS: I attained a two shot pfizer vaccine and then a two shot booster so in total I attained 4 shots all pfixer.  Thank you for your time.
On 9/15/2022 I started to notice the pain in my lower back. It was gradual at first and it increased overtime. On 10/10/2022, I went to see my rheumatologist. He gave me 2 cortisone shots on my hips. He diagnosed me with Bursitis. I have not recovered from the adverse event I have to return for a follow up.
Patient said he started having redness that night and getting chills. He went to the Doctor two days later and was given a ROCEPHIN shot and BACTRIM DS.
Mother called in reports: Rt. arm with rash at injection site & shoulder area, c/o arm hurts, lightheadedness, nausea intermittently, c/o nausea 20 minutes after left clinic. Mother denies giving Ibuprofen or MOTRIN, has applied Hydrocortisone ointment to rash without noticeable change. Denies fever, signs of infection at injection site.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; SEVERE DAILY HEADACHES; This spontaneous report received from a patient concerned a 41-year-old white, female. The patient's height, and weight were not reported. The patient had no medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) 1 total, dose was not reported, administered on 20-MAR-2021 at right arm for prophylactic vaccination. No concomitant medications were reported.  The patient reported that 3-5 days (on MAR-2021) after receiving the vaccine, she developed severe daily headaches for 1 month. The patient stated that massages on her head provided some relief at the time and that she rarely ever had headaches prior to receiving the vaccine. The patient noted that on 18-APR-2021 she saw doctor regarding the headaches and took 2 weeks off work. No testing was done and no medications were prescribed. When the patient returned to work, she noted that the headaches became less often, diminished and light, occurring once every 3 months. On 06-JAN-2022, tested positive for Covid-19- via PCR (polymerase chain reaction) testing (confirmed covid-19 infection and confirmed clinical vaccination failure). On an unspecified date the patient developed a cough, little bit of a headache, fever for 4 days, body aches and runny nose. The patient was still coughing at the time of reporting. Laboratory data included: SARS-CoV-2 PCR test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe daily headaches, and confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000213264.; Sender's Comments: V0:20220139528-COVID-19 VACCINE AD26.COV2.S-Confirmed clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Starting shortly after the shot I became dizzy light headed and nauseated with a rash on my neck and chest with a fever of 101.87 very weak and lethargic. Later that night experienced vomiting and diarrhea no appetite. The next morning still had my fever still feeling dizzy no appetite very pale and with head ache still lethargic. Day three I had a fever of 99.7 still very dizzy had small rash and I was very weak went to Urgent Care. It is now March 2 2011 I am still experiencing no appetite nausea small fever and fatigue.
Extreme nausea ,  headache,  stomach ache,  fever, chills   starting approximately 2:00am  2/21/21
pt recvd 3 doses of Engerix-B & the next day exp a rash on face & arms; Event resolved w/o treatment; 1 of 2 pts who exp a rash @ this facility;
Feeling dizzy, sweaty. Legs were elevated and given a snack and water. Began to feel better.
My Mother received the shot at 10:30 am at home.  She is on hospice, in a wheelchair.  By 11:00 am she started to become unresponsive.  By 1:00pm she was unable to blink her eyes, move her mouth, lift any limbs, open her mouth, or swallow water.  She was completely helpless and appeared paralyzed.  This did not go away until after 5:00 pm when she was able to swallow water fed to her.  By 7:00 pm she was responsive, but extremely weak.  It took a few days for her to regain her strength. The only reason she was given this shot was that it was required for her upcoming admission into a skilled nursing facility.
Right hand/forearm tingling and numb, feels like it does when it goes to sleep. 24/7. Testing with ibuprofen and muscle simulation
This non-serious spontaneous case, initially received from other non-health professional on 13-Nov-2018, concerns a 72-year-old, elderly patient of an unspecified gender. It was reported that, the FLUAD (TIV) vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 24-Oct-2018, the patient was administered FLUAD (TIV) [batch number: 250802, dose, route of administration, anatomical location and expiry date: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805511 was crossed linked to original cases 201804863 due to same reporter.
pt recvd vax & exp an inject site react; devel a large, red, hot, itchy area (described as the size of mom's hand); not seen in office; office visit scheduled;
12/12/2023 I was on the phone and all of a sudden, I dropped the phone and had complete weakness in my left arm. I went to the ER, and I was diagnosed with a mini stroke (TIA), They gave me an EKG, MRI and a CBC, I was given a heart monitor to wear overnight for one month. The results were normal. I also want to report that I have had a bladder infection for the past 2 weeks and they have found blood in my urine. I am currently on antibiotics. I have a follow up appt with the Urologist on May 2nd.
Patient states that when he got the vaccine he did not feel the pharmacist give it to him, so he does not think it went into the muscle. The next day following vaccination the patient had a sore arm similar to what he experienced with the first dose. This sore arm progressively became worse and has not gotten any better since the pain began and it has now been over 3 months since he received the vaccine. Patient has a decreased range of motion and experiences severe pain that lasts approximately 2 minutes anytime he moves his shoulder. He states his quality of life has diminished because daily tasks like putting on a t-shirt are very painful and the chronic pain meds that he already takes regularly do not help. He mentioned the shoulder pain during a virtual pain management visit today and the nurse practitioner suggested that he may have bursitis due to where the vaccine was injected. I recommended the patient follow-up with his PCP for the possibility of being referred to physical therapy.
Had a fever and chills and headaches starting the evening of March 31. Fever and chills wore off on April 1 but short sharp headaches have persisted  every few hours since evening of April 1st.
Terrible lower back pain, very sore arm at injection sight, flu-like symptoms (fever, chills, fatigue, nausea) on second day, rash on entire torso beginning on second day, third day chest and shoulder area became extremely red like I had a severe sunburn (very itchy and uncomfortable).  I am now one week out from the booster and my shoulders are actually peeling as if I had a sunburn.  Extremely uncomfortable...I would NEVER take another shot of this vaccine.
This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) and HEADACHE (Slight headache) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) and HEADACHE (Slight headache). The patient was treated with PARACETAMOL for Headache, at a dose of 1 dosage form. On 05-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) had resolved. At the time of the report, HEADACHE (Slight headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided.
satellite pustules and papules over upper torso and upper arms developed after smallpox vaccine administered 11 Apr 2007
Patient called health dept and complains of significant left knee swelling and difficulty moving post vaccination 48 hours later after both shots. She reports having an artificial knee replacement in December of 2019.  She reports that her pain and movement is improved, but she is not back to her "norm".
Symptoms began within approx 2 hours of receiving vaccine. Symptoms included: Fever of 101.7 that lasted 16-18 hours, chills, very sore arm, swelling of upper arm, very dark bruising at injection site and down the arm (immediate bruise was round, surrounded injection site, was dark purple and measured approx 40mm; bruising extended down the arm to a total of 100mm). Patient stated she took hydrocodone to relieve the pain in the arm.
ADMINISTERED TO 17 YEAR OLD; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 17 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced administered to 17 year old, and off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administered to 17 year old and off label use was not reported. This report was non-serious.
additional adverse event reported; called about a temperature excursion and a improper storage; This spontaneous report has been received from a medical assitant, referring to a patient of unknown age and gender.The patient's concurrent medications, pertinent medical history, drug reactions or allergies were not reported.  On 04-JUN-2021, the patient was vaccinated with an improperly stored  the patient was vaccinated with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast)(GARDASIL 9) 0.5 milliliter , intramuscular , lot number S028738 , expiration date : 03-APR-2022 ,as prophylaxis  The vaccine was exposed to a temperature excursion of 50.9 °degree F for a time frame of 2 hours and 49 minutes, which were detected by the Digital Data Logger. There was no previous temperature excursion. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S028738; expirationdate: 03-APR-2022; deviceage and unit: 0 ; malfunction: Unknown; productavailableforevaluation: No; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Upon waking from afternoon nap had fever of 104.4 rectal. Had been treated with ibuprofen prior to shot administration at 12:20. Treated with acetaminophen at 4:15.
This case was reported by a pharmacist and described the occurrence of increase in migraine in a 25-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). Concurrent medical conditions included migraine. Concurrent medications included TREXIMET. On 1 December 2008 at 17:10 the subject received a dose of FLULAVAL at 0.5 ml in the left arm. On 4 December 2008, 3 days after vaccination with FLULAVAL, the subject experienced increase in migraine (worsening) and bruising at the injection site. She also noted new bruising on her legs the same day. Increase in migraines and injection site bruising was improved at the time of reporting. The outcome of bruising on the legs was not reported.
Persistent abnormal physical findings include, low grade fever(99-100.5), flushing and tachycardia. Abnormal lab is mild lymphopenia. Significant symptomatic relief with Beta Blocker (low dose propranolol). Pt was previously healthy and vigorous. Abnormal symptoms and signs have persisted for over 6 months, but might be gradually remitting. Other various symptoms include: joint pain, lack of energy, tired, numbness in legs and upper back, chest pains, nausea and coughing. Consultation report shows:BP R130/100 L140/100, erythema down to upper chest, has a little fluid in right knee, but wnl.
This case was reported by a healthcare professional (nurse) who is also the patient and described the occurrence of abdominal lymph nodes enlarged in a 38-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medical conditions included allergy to soy. Concurrent medications included ACIPHEX. In either 2006 or 2007 the subject received unspecified dose of ENGERIX B (unknown). On 31 October 2013, six or seven years after vaccination with ENGERIX B, the subject experienced not responding to therapy. The subject did not develop hepatitis B antibodies when she received the vaccine while in nursing school, she was tested on 31 October 2013. At an unspecified time after vaccination with ENGERIX B, the subject experienced abdominal lymph nodes enlarged and liver biopsy. She reported that she now has enlarged lymph nodes in her abdomen, received three liver biopsies, two PET (Positron emission tomography) scans and an esophageal ultrasound. No other details were provided included the relevant test results. The subject was hospitalized, details not provided. At the time of reporting the outcome of the not responding to therapy, abdominal lymph nodes enlarged and liver biopsy were unspecified.
Took Tylenol and used the lotion I was  prescribed right after the vaccine - that helped as my Arm just hurt a little that night. There was a little redness but it didn't grow like the other one did. Next  day, I had a fever, chills and that lasted about 24 hours. I stayed in bed that day.
Patient first noticed arm red and swollen 12/20/10 in the evening after inj. given the next day 12/21/10 pt mom - noticed and stated entire back of pt (L) upper arm red, swollen and warm to touch on 12/22/10 pt mom contacted clinic arm assessed and red, swollen, warm to touch area approx 3" long and 1" wide mom instructed to give pt BENADRYL & monitor 12/23/10 pt mom contacted she stated area cont. to decrease in size. No SOB or other adverse reactions ever noticed on pt. No fever noted either.
PAIN; CHILLS; HEADACHE; MUSCLE ACHES; FEVER; This spontaneous report received from a patient concerned a 47 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1808978 expiry: /2023) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced pain. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced muscle aches. On 08-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100.9. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, headache, muscle aches, fever, and pain. This report was non-serious.